搜索结果161-170 的 827 / anti-TNF drugs

1. 神经科- 临床试验- 妙佑医疗国际

   To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

2. Noninvasive radiologic biomarkers to individualize lung cancer therapy - 妙佑医疗国际

   Noninvasive radiologic biomarkers to individualize lung cancer therapy. Share; Doximity · Facebook · LinkedIn · Twitter; Print details. MAC-20430586. 医疗专业 ...

3. 内分泌科- 临床试验- 妙佑医疗国际

   ... therapy using FDA-approved weight loss medications and EBMTs with or without concomitant medical therapy. A Study to Evaluate CHIP and Hematological ...

4. 羟氯喹是否可用于治疗COVID-19？ - 妙佑医疗国际

   U.S. Food and Drug Administration. https://www.fda.gov/drugs/emergency-preparedness-drugs/emergency-use-authorizations-drugs-and-non-vaccine-biological-products ...

5. 女性健康- Mayo Clinic 新闻 - 妙佑医疗国际

   What's the best nonhormonal therapy for hot flashes? Experts release new menopause therapy guidelines May 31, 2023, 05:15 p.m. CDT · Mayo Clinic Minute: What ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... therapy. Evaluating Optic Nerve Disease with OCT Angiography. Rochester, Minn. The purpose of this study is to determine if optical coherence tomography (OCT) ...

7. 肌萎缩侧索硬化症（ALS） - 诊断与治疗- 妙佑医疗国际

   New Drug Application 216660. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process ...

8. 神经科- 临床试验- 妙佑医疗国际

   To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

9. 神经科- 临床试验- 妙佑医疗国际

   To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...